HeartWare Studies Less-Invasive HVAD Implant Technique
This article was originally published in The Gray Sheet
The 120-patient, single-arm LATERAL trial will evaluate a thoracotomy technique for implanting the HVAD ventricular assist device in bridge-to-transplant patients.
You may also be interested in...
Although near-term challenges have slowed growth in the market for left ventricular assist devices (LVADs), companies are developing new, less invasive VADs with improved pump designs to further improve patient outcomes and allow for a wider application of the therapy in treating heart failure. These next-generation VADs are fueling long-term optimism in the market for mechanical circulatory support, which remains one of the more attractive opportunities in the cardiovascular space.
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.